Highlights
Introduction
NUPR1 is a stress-inducible 82-aminoacids long, intrinsically disordered member of the AThook family of chromatin proteins. NUPR1 was first described as being activated in the exocrine pancreas in response to the cellular injury induced by pancreatitis (Mallo et al, 1997) , an inflammatory disease, which in its chronic form, behaves as a preneoplastic condition for pancreatic cancer. Subsequently, the inducible expression of Nupr1 was discovered to be a surrogate of the stress response caused by many stimuli in most cell types (Garcia-Montero et al, 2001 ) characterizing NUPR1 as a typical stress-associated chromatin protein. NUPR1 binds to DNA in a similar manner to other chromatin proteins (Encinar et al, 2001; Grasso et al, 2014) so as to control the expression of gene targets (Hamidi et al, 2012a) . At the cellular level NUPR1 participates in many cancer-associated process including cell-cycle regulation, apoptosis (Malicet et al, 2006a; Malicet et al, 2006b) , cell migration and invasion (Sandi et al, 2011) , and DNA repair responses (Gironella et al, 2009 ). Indeed, NUPR1
has recently elicited significant attention due to its role in promoting cancer development and progression in the pancreas Hamidi et al, 2012a) . NUPR1-dependent effects also mediate resistance to anticancer drugs (Giroux et al, 2006; Palam et al, 2015; Tang et al, 2011) , an important characteristic of this malignancy. We (Sandi et al, 2011; Vasseur et al, 2002b) and others (Emma et al, 2016; Guo et al, 2012; Kim et al, 2012; Li et al, 2017; Zeng et al, 2017) have shown that genetic inactivation of Nupr1 antagonizes the growth of tumors in several tissues, including pancreatic cancer (Sandi et al, 2011) thereby supporting a role for this protein as a promising therapeutic target for the development of therapies for pancreatic cancer. Congruently, using a comprehensive approach that combines biophysical, biochemical, computational, and biological methods for repurposing FDA approved drugs in the treatment of pancreatic cancer, we have recently identified that the phenothiazine derivative, trifluoperazine, mimics the effect of the genetic inactivation of NUPR1, revealing its anticancer properties (Neira et al, 2017) . The current study was designed to better understand the mechanisms by which targeting NUPR1 results in its tumor growth-inhibiting effects. We focused on determining the specific intracellular pathways that result in cell death after Nupr1 inactivation in vivo (Nupr1-deficient mice) and in vitro (knockdown by either siRNA or CRISPR-Cas9). We found that in NUPR1-deficient cells, glucose consumption was switched from OXPHOS towards glycolysis resulting in a significantly reduced ATP production that promoted a caspase-independent programmed necrotic process. This defect was due to a mitochondrial malfunction, which in turn resulted from a strong ER stress. This report constitutes the first demonstration that inactivation of NUPR1 antagonizes cell growth by coupling two pathobiological cell phenomena, namely ERstress response and caspase-independent necrosis.
Results

Genetic inactivation of NUPR1 induces pancreatic cell death by necrosis
In several in vitro and in vivo models of pancreatic cancer, NUPR1 inactivation inhibits the development and growth of this malignant tumor, highlighting the translational importance of this protein. However, the molecular mechanisms underlying these phenomena remain poorly understood. Previous work has demonstrated that Nupr1 expression is rapidly and significantly induced by endoplasmic reticulum (ER) stress (Carracedo et al, 2006; Salazar et al, 2009 ). We therefore, evaluated the role of NUPR1 during ER stress by inhibiting its expression in ER-stressed cells. To carefully define this phenomenon, ER stress on pancreatic cancer cells (MiaPaCa2) was induced by using brefeldin A, thapsigargin or tunicamycin in combination with decreased the levels of NUPR1 using two different siRNAs ( Figure S1 ). Subsequently, the necrotic and the apoptotic effects were measured through LDH release and caspase 3/7 activity, respectively. Upon ER stress induction, we found that LDH release was significantly higher in NUPR1 siRNA-transfected cells than in control cells ( Figure 1A) .
Similarly, caspase 3/7 activity was also greater in NUPR1-depleted cells ( Figure 1B) .
Combined, these experiments demonstrated that NUPR1 exerts both anti-apoptotic and anti-necrotic effects even in basal conditions, as well as during ER stress. Interestingly, pretreatment with the pan-caspase inhibitor, zVAD-FMK, did not prevent LDH release, as shown in Figure 1A , indicating that the role of NUPR1 to counteract necrosis is independent of its anti-apoptotic mechanism. We also used flow cytometry after co-labelling cells with Annexin V and PI to measure apoptosis and necrosis, respectively, in genetically NUPR1depleted cells after brefeldin A, thapsigargin or tunicamycin treatment. Transfection with siRNAs against NUPR1 increased apoptotic and necrotic events, both in untreated and ER stressor-treated cells as presented in Figures 1C and D, which is in line with the data obtained concerning caspase 3/7 activity and LDH release. Inactivation of the Nupr1 expression in Panc-1 cells ( Figure S1 ), using a CRISPR-Cas9 knockout strategy, resulted in similar consequences, as shown in Figures 1E and F. Congruently with that data, after reconstitution of NUPR1 expression in CRISPR-Cas9 knockout Panc-1 cells by transfecting a NUPR1-expression vector, cell viability was almost completely rescued (Figures S2 and S3) .
Altogether, these data indicate that inactivation of NUPR1 increases the sensitivity of cells to apoptosis and to necrosis, and that the necrotic process is independent of caspase 3/7 activation. Thus, this data demonstrate that cell death after inactivation of NUPR1 occurs by a combination of both, apoptotic and necrotic processes.
NUPR1 inactivation decreases ATP production
Since the normal production and handling of ATP as both an energetic and signalingassociated molecule is vital for cells (Golstein & Kroemer, 2007) , we evaluated if ATP metabolism was implicated in the effects of NUPR1 inactivation on necrosis and apoptosis.
Notably, we found that the levels of ATP were significantly reduced in cells transfected with Nupr1 siRNAs, in untreated and in ER-stressed cells (Figure 2A ). Again, inhibition of caspase 3/7 activity did not prevent this effect. Consequently, we considered that the decrease in the intracellular ATP content might be the result of reduced efficiency of the mitochondrial metabolism or decreased substrate availability for synthesizing these molecules within the cells (Kroemer & Pouyssegur, 2008) . To address this issue, we therefore evaluated the mitochondrial oxygen consumption rate (OCR) at basal conditions as well as after treatment with an inhibitor of ATP synthase, oligomycin, or a potent mitochondrial oxidative phosphorylation uncoupler, carbonilcyanide p-triflouromethoxyphenylhydrazone (FCCP).
Oligomycin treatment allowed the calculation of the OCR used by mitochondria exclusively for ATP production, while FCCP injection estimated the maximal respiration capacity of this organelle under stress situations. We measured the OCR in pancreatic cancer cells with Nupr1 siRNA-mediated knockdown ( Figure 2B ) or inactivation by CRISPR-Cas9 ( Figure 2C ), as well as in pancreatic acini obtained from Nupr1-KO and WT mice ( Figure 2D ). Interestingly, compared with control cells, the OCR was strongly decreased in cells depleted of NUPR1 by siRNAs or CRISPR-Cas9-based knockout at basal respiration, as well as at the maximal respiration capacity ( Figures 2B and 2C ). In addition, we found that the OCR was drastically reduced in Nupr1-KO acini isolated from animals compared to those from WT mice ( Figure   2D ). Then, in order to evaluate if the oxidization of any of the main fuels used by the mitochondria for ATP production, which are glutamine, fatty acids, and glucose, could be compromised in NUPR1-inhibited cells, we used the Mito Fuel Flex Test. Measurements were obtained of the OCR for the basal respiration by the cells, and subsequently, we inhibited glutamine, fatty acid, or glucose metabolism for mitochondrial ATP production with BPTES, etomoxir, and UK5099 respectively. A decrease in the OCR after these methods of inhibition would indicate that the cells were metabolizing the substrate. Indeed, we found that after the injection of any of these three inhibitors, there was a decrease in the OCR ( Figure 2E ) in control cells. In contrast, in NUPR1-depleted cells, after the inhibition of the glutamine, fatty acid, or glucose oxidation, mitochondrial OCR was not modified as shown in Figure 2E . These results indicate that mitochondria are not appropriately oxidizing these substrates to generate ATP in the absence of NUPR1. Congruent with these results, we found that the expression of distinct enzymes involved in the tricarboxylic acid cycle, such as SDHA, FH, PDHA, and IDH2, was significantly downregulated in NUPR1-depleted cells as presented in Figure 2F . Since O 2 -dependent ATP production is inefficient in NUPR1-deficient cells, we evaluated the energy production by anaerobic glycolysis, measured as the extracellular acidification rate (ECAR) by the proton efflux into the media during lactate release. These experiments demonstrated that the ECAR increased under basal glycolysis and during inhibition of mitochondrial respiration after oligomycin treatment (glycolytic capacity) in NUPR1-depleted cells ( Figure 3A ), thereby resulting in lower cellular reserves of glucose. An increase in ECAR values was also observed with CRISPR-Cas9 knockout Nupr1 cells, as shown in Figure 3B , corroborating this effect. Furthermore, in pancreatic acini obtained from Nupr1-KO and WT mice, we found that Nupr1 -/acini used more anaerobic glycolysis than WT, with a consequent reduction in the intracellular reserve of glucose ( Figure 3C ). This observation was also confirmed by directly measuring lactate release into the culture media by NUPR1-deficient cells ( Figure 3D ). We also detected a significant increase in glucose uptake in NUPR1-defficient cells ( Figure 3E ), whereas glutamine uptake remained unchanged ( Figure 3F ). Finally, measuring the OCR and the proton production rate by cells in the extracellular medium showed a rate of ATP production by glycolysis in control cells of 14.63 ± 1.30 pmoles/min/1000 cells, which represented 12.67% of the total ATP produced. For the siNUPR1-1-and siNUPR1-2-transfected cells, the rate was 22.75 ± 1.59 and 22.26 ± 0.80, respectively, which represented 32.43% and 30.74 % of the total ATP production ( Figure 3G ).
Accompanying these events, we also found that several genes involved in glycolysis, such as PDK, GPI, TPI, PGK1, and PGAM1, increased their expression ( Figure 3H ). Taken together, these results strongly support a model whereby, under NUPR1 deficiency, the ATP production by glucose is switched towards glycolysis instead of OXPHOS. However, glycolysis is less efficient in terms of ATP production than OXPHOS, and therefore, the glucose reserve is rapidly consumed. Thus, NUPR1-depleted cells are limited by intracellular ATP availability, which contributes to the triggering of cell death by necrosis.
NUPR1 inactivation alters the function and localization of mitochondria
The results described above demonstrate that inactivation of NUPR1 induces a defect in mitochondrial OXPHOS activity, which is evidenced by the strong decrease in O 2 consumption and ATP production, even if the cell attempts to compensate by activating the production of ATP through glycolysis. Consequently, we further evaluated the normal functioning of the mitochondria in cells in which NUPR1 had been genetically inactivated.
First, we evaluated the proton gradient by measuring the membrane potential using the Mito ID system. In mitochondria, proton gradients generate a chemiosmotic potential known as the proton motive force which is used for the synthesis of ATP by OXPHOS, Ca 2+ uptake, and antioxidant defense. The measurement of the chemiosmotic potential is a key indicator of mitochondrial and cell health or injury. In NUPR1-depleted cells, we found a significant depolarization of the mitochondrial membrane which is reflected by a decrease in the fluorescence of dye, as presented in Figure 4A and B, which explains, at least in part, the observed defect in ATP production. We then measured superoxide anion production by the mitochondria using the MitoSOX reagents, by both fluorescent microscopy and flow cytometry. These studies are important since superoxide anion generation by mitochondria triggers oxidative damage and contributes to retrograde redox signaling from the organelle to the rest of the cell. In this regard, both flow cytometry and fluorescence microscopy showed a significant increase in the intracellular levels of superoxide anions in NUPR1deficient cells ( Figures 4C and 4D ). Thus, these experiments clearly demonstrate that NUPR1 inactivation affects the function of mitochondria, which explains the impact on ATP metabolism described above. The cellular distribution of mitochondria was analyzed in NUPR1-deficient cells using the MitoTracker Deep Red reagent counterstained with Alexa Fluor 488 phalloidin for cytoplasm and DAPI staining for the nucleus. The images shown that the distribution of these organelles remained localized in a limited perinuclear region, which differed from control cells, where mitochondria were more homogeneously localized throughout the cytoplasm as a structured network ( Figure 5A ). Transmission electron microscopy analysis of the mitochondria confirmed their limited perinuclear localization and the absence of significant ultrastructural changes of the organelle ( Figure 5B ). Through these experiments, we found no apparent change in the overall number of mitochondria in NUPR1-deficient cells ( Figure 5C ). However, these techniques revealed that mitochondria of the NUPR1-deficient cells were almost always associated with the ER, which was enlarged, as often observed during ER stress ( Figure 5D ). We therefore sought to gain insight into whether this observation indeed indicated that Nupr1-defficient cells were undergoing ER stress by measuring intracellular Ca 2+ concentration using flow cytometry. Indeed, one of the most typical features of ER stress is the massive Ca 2+ release from the stressed ER to the cytoplasm, which causes Ca 2+ to move from the ER to mitochondria. We found a considerable increase in this parameter with values that resemble those found in our positive controls of ER Ca 2+ release, namely brefeldin A-or tunicamycin-treated cells ( Figure   5E ). Concomitantly, we found a significant downregulation in the expression of two genes:
TFAM, which encodes a key mitochondrial transcription factor that functions in mitochondrial DNA replication and repair, and NRF1, which encodes a transcription factor that activates expression of nuclear genes required for respiration and mitochondrial DNA transcription and replication ( Figure 5F ). In contrast, expression of LONP1, a gene encoding a mitochondrial protease involved in the selective degradation of misfolded, unassembled, or oxidatively damaged polypeptides in the mitochondrial matrix, and PINK1, a gene encoding for a serine/threonine protein kinase that is thought to protect cells from stress-induced mitochondrial dysfunction, were overexpressed ( Figure 5F ). Altogether, these results reveal a malfunction and abnormal subcellular distribution of mitochondria which may be due to the massive Ca 2+ release from the stressed ER in NUPR1-deficient cells.
NUPR1 inactivation induces failures in ER stress response
Nupr1 expression is strongly induced in response to ER stress, but its role in ER stress response, if any, remains to be established. In fact, the ER stress response is accompanied by the activation of several ER stress-associated genes (Kato & Nishitoh, 2015) , with unknown roles in this process for some of them. We therefore evaluated the role of NUPR1 in the ER stress response using several complementary approaches. The transcriptome of the MiaPaCa2 cells treated with a siRNA against Nupr1 revealed a downregulation of several genes involved in ER stress-associated pathways when analyzed by both the Ingenuity Pathways Analysis (http://www.ingenuity.com/) and STRING (Szklarczyk et al, 2015) bioinformatics tools. The most significant biological pathways identified as inefficiently activated in NUPR1-deficient cells were: the response to unfolded protein (30 mRNA downregulated, FDR 7.53e-40), protein folding (28 mRNA downregulated, FDR=1.1e-32), the ER unfolded protein response (17 mRNA downregulated, FDR=1.55e-19), regulation of translational initiation (13 mRNA downregulated, FDR=2.95e-15), response to ER stress (16 mRNA downregulated, FDR 9.98e-14), the ER-nucleus signaling pathway (8 mRNA downregulated, FDR=1.48e-10), the ATF6-mediated unfolded protein response (6 mRNA downregulated, FDR=1.48e-10), the PERK-mediated unfolded protein response (6 mRNA downregulated, 1.33e-09), chaperone-mediated protein folding (8 mRNA downregulated, FDR=2.17e-09), response to stress (32 mRNA downregulated, FDR=5.97e-06), and the IRE1mediated unfolded protein response (6 mRNA downregulated, FDR=2.14e-05) (see Table 1 and Table S1 ). These experiments, designed to directly evaluate the effects of NUPR1 in exocrine pancreatic cells, demonstrate that gene expression networks associated to ER stress are among the top pathways associated with expression changes under these conditions. To confirm these experiments in vivo, we made use of the Nupr1-KO mice model.
Interestingly, transcriptomic analysis of pancreata from these mice analyzed using the same bioinformatics tools, also revealed an inefficiency in the ER stress response, for some of these biological processes, such as: the response to ER stress (10 mRNA downregulated, FDR=7.73e-12), response to unfolded protein (7 mRNA downregulated, FDR 6.82e-09), protein folding (7 mRNA downregulated, FDR=6.81e-07), ER unfolded protein response (5 mRNA downregulated, FDR=1.94e-06), cellular response to unfolded protein (5 mRNA downregulated, FDR=2.15e-06), and response to stress (12 mRNA downregulated, FDR=0.00255) (see Table 1 and Table S2 ). Thus, these results from our animal model, combined with those obtained in cells, show that NUPR1 deficiency mounts an inefficient ER stress response.
Subsequently, we measured the expression of several genes involved in controlling the ER stress response, in NUPR1-depleted MiaPaCa2 cells, such as ATF6, IRE1α, PERK, EIF2A, XBP1, ATF4, CANX, CALR, BIP and HSP90 by RT-qPCR. Notably, some of these genes demonstrated significantly decreased expression in the absence of NUPR1 expression although not BIP and HSP90 ( Figure 6A ). In addition, expression of ATF6, IRE1α, PERK and BIP proteins was also measured by western blot on the siNUPR1-1-and siNUPR1-2-treated MiaPaCa2 cells.
Interestingly, whereas levels of ATF6, IRE1α and PERK were decreased in NUPR1-depleted cells, BIP protein levels remained unaffected in strong correlation with its mRNA ( Figure 6B ).
Altogether, these data suggest that expression of NUPR1 is necessary for an optimal ER stress response, which occurs, at least in part, through control of these genes at the transcriptional level. Therefore, when NUPR1 is inactivated, the ER stress response is suboptimal, with dramatic consequences on mitochondrial function and a strong deficit in ATP production, and as main consequence, cell death by necrosis is induced.
NUPR1 expression protect acinar cells of necrosis in mice with acute pancreatitis
During the course of pancreatitis, there is a sustained ER stress and pathological calcium signaling (Sah et al, 2014) . Thus, we analyzed the effects of NUPR1 inactivation on cell death induced by experimental pancreatitis in Nupr1-knockout (KO) and WT mice. As shown in Figures 7A and B, we found that acute pancreatitis, induced by repeated injections of caerulein, resulted in a higher serum concentration of lipase (i.e.: 1248 ± 39 U/L and 715 ± 45 U/L after 12 h of induction in KO and WT mice respectively; p=0.0009) and lactate dehydrogenase (LDH) (i.e.: 4247 ± 198 ng/ml and 2034 ± 119 ng/ml after 12 h of induction in KO and WT mice respectively; p=0.002). Congruent with a role of NUPR1 in cell death by necrosis in acute pancreatitis, Nupr1-KO mice displayed a higher necrotic score when compared with wild type littermates ( Figure 7C ). Thus, this in vivo experiment demonstrates that normal levels of NUPR1 are necessary for protecting pancreatic cells from necrotic cell death.
Discussion
The current study significantly contributes to a better understanding of mechanisms underlying the regulation of cell death by the cancer-associated protein, NUPR1. Our data support the idea that NUPR1 activation is strongly involved in protecting the cell against programmed cell death by both apoptosis and necrosis, and therefore, targeting NUPR1
protein in cancer appears to be a promising tool as an anticancer therapeutic strategy.
Several empiric observations have shown that cancer cells undergo growth arrest or cell death after genetic inactivation of NUPR1 in vitro and in vivo (Emma et al, 2016; Guo et al, 2012; Kim et al, 2012; Li et al, 2017; Sandi et al, 2011; Vasseur et al, 2002b) . However, to date, the mechanisms responsible for the biological consequences of its inactivation in cancer cells remain poorly understood. In this work, we used a battery of complementary methodological approaches to study these mechanisms, including Nupr1-KO mice, two siRNA sequences and CRISPR-Cas9 to inhibit NUPR1 expression with systematically concordant results. Notably, inactivation of this protein prevents pancreatic cells from properly responding to ER stress induced in vitro and leads to spontaneous metabolic cell death. We demonstrate that the inactivation of Nupr1 in pancreatic cells promotes a cascade of events with several important consequences. For instance, loss of NUPR1 results in lower ATP production, higher consumption of glucose, a partial switch from OXPHOS to glycolysis, and a perinuclear relocalization of mitochondria to the vicinity of the ER. We also found that NUPR1 inactivation triggers a massive release of Ca 2+ from the ER to the cytosol and a strong increase in ROS production, even though mitochondria produced less ATP. Altogether, these data enable us to describe a model in which inactivation of NUPR1 in pancreatic cancer cells results in an inefficient ER stress response through the inappropriate expression of several ER stress-associated genes. However, this adaptive attempt of the cell is counteracted by the increased Ca 2+ concentration in the cytoplasm, which as shown previously (Berridge, 2002) , leads to an increased mitochondrial Ca 2+ concentration, disruption of mitochondrial membrane potential, leak of electrons from the respiratory chain in the complexes I and III (Brookes et al, 2004) , ultimately resulting in a ROS accumulation, and, most importantly, in lower ATP generation. The low level of ATP production by NUPR1-deficient cells seems to be partially compensated by switching the remaining glucose consumption to glycolysis.
However, this is insufficient to survive and therefore a metabolic cell death ensues.
NUPR1 was previously described as a protective factor against pancreatitis-induced lesions by activating expression of the anti-inflammatory factor pancreatitis associated protein I (also known as PAPI or Reg3beta) (Vasseur et al, 2004) , in part through regulating its transcriptional activation. In turn, PAPI/Reg3beta inhibits the activation of NFkappaB in macrophages and therefore acts as a powerful anti-inflammatory factor (Folch-Puy et al, 2006) . Consequently, the anti-inflammatory effect of NUPR1 could be explained through the activation of the PAPI/Reg3beta. Surprisingly, in this work we are demonstrating that experimental pancreatitis induced in NUPR1-deficient mice results in a significant increase in necrosis as indicated by the greater release of LDH, amylase and lipase in blood during the acute phase of the disease and by the significant increased necrotic score. Altogether, these results strongly suggest that induction of NUPR1 during acute pancreatitis controls both, inflammation and necrosis, by two different and complementary mechanisms.
A metabolism-associated role of NUPR1 was previously suggested in hepatocellular carcinoma, in which expression of Nupr1 is induced in response to the mitochondrial malfunction, and consequently, NUPR1 overexpression favors cancer progression (Lee et al, 2015a; Lee et al, 2015b ). In addition, it was also demonstrated that NUPR1 overexpression is necessary in the liver for an optimal response to a non-essential aminoacids-deficient diet and in pancreatic cancer cells to a starved culture media (Hamidi et al, 2012a; Maida et al, 2016) . Based on these observations, we can assume that overexpression of NUPR1 operates to improve mitochondrial function to produce a maximum of energy in the presence of low substrates under stressed conditions. Finally, we previously demonstrated that deficiency in NUPR1 expression results in induction of cellular cannibalism (Cano et al, 2012) and autophagy (Kong et al, 2010) processes. In light of the results from the current study, it is tempting to speculate that both cannibalism and autophagy could serve to generate energy fuel in NUPR1-deficient cells to compensate for the ATP deficiency. In addition, since intracellular ATP deficiency is accompanied by an increase in AMP and therefore activation of AMPK, it is possible that this kinase signals the initiation of the autophagy (Russell et al, 2014) and cellular cannibalism processes (Poels et al, 2012) .
In conclusion, this current work demonstrates that, in NUPR1-deficient cells, glucose consumption is switched towards glycolysis instead of OXPHOS, which in turn results in a poor ATP production, and the natural promotion of a programmed necrotic process that we termed metabolic cell death. This defect is due to a mitochondrial malfunction, which in turn results as a consequence of a deficient ER stress response induced by the lack of NUPR1 expression.
Materials and methods
Animals: Nupr1 -/mice bear a homozygous deletion of exon 2 and have been reported previously (Vasseur et al, 2002a) . The Pdx1-cre; LSL-Kras G12D mice were provided by R. Induction of experimental pancreatitis: Pancreatitis was induced in 4-month-old Nupr1 -/and Nupr1 +/+ mice weighing 20-24 g. Caerulein (Sigma) was administered as intraperitoneal injections of 50 μg/kg body weight, as previously described (Halangk et al, 2000) . Salineinjected animals served as controls.
Preparation of isolated pancreatic acinar cells:
Briefly, 5-week-old mice pancreata were immediately removed after euthanasia, cut into small sections, and digested with collagenase IA (Sigma-Aldrich) for 10 min at 37°C as previously described (Santofimia-Castano et al, 2015) . Acini were collected by centrifugation at 30 g for 5 min, washed and resuspended in Seahorse medium, and plated in pre-coated Cell Tak (Corning) Seahorse plates (Agilent).
Preparation of serum and tissue samples:
Mice were sacrificed at several time points from 3 to 24 h following the first intraperitoneal injection of cerulein. Whole blood samples were centrifuged at 4°C, and serum was stored at -80°C. The pancreas was removed on ice, immediately frozen in liquid nitrogen, and stored at -80°C.
Necrosis score evaluation: Formalin-fixed samples were embedded in paraffin and 5-μm sections were stained with hematoxilin and eosin. The histological alterations in the sections were scored by three experienced reviewers. The scores refer to ranges of percentages of cells involved from 0 (absent), 1 (minimal, 0 to 15%), 2 (moderate, 15 to 35%), 3 (important, 35 to 50%) to 4 (maximal, >50%).
LDH and lipase serum concentration:
A Cobas analyzer was used to measure enzyme concentrations in the serum samples of Nupr1 -/and Nupr1 +/+ mice, according to the manufacturer's specifications and using proprietary reagents.
RNA-seq:
RNA from pancreata of 5-week-old mice was purified following the procedure of Chirgwin et al. (Chirgwin et al, 1979) . RNA integrity was assessed using the Agilent 2100
Bioanalyzer with the RNA 6000 Nano chip Kit. Samples were sent to the Transcriptomic and Genomic platform of Marseille-Luminy (TGML). The enrichment of mRNA, cDNA library construction for RNA-seq, sequencing, and bioinformatic data analysis were performed as previously described (Amrani et al, 2014) . Electron microscopy: Samples were prepared using the NCMIR protocol for SBF-SEM (Deerinck et al, 2010) . 70 nm-ultrathin sections were prepared using a Leica UCT Ultramicrotome (Leica, Austria) and deposited on formvar-coated slot grids. The grids were observed in an FEI Tecnai G2 at 200 KeV and acquisition was performed on a Veleta camera (Olympus, Japan).
DNA microarray:
Total RNA (15 μg) was isolated and reverse transcribed for hybridization to the human oligonuleotide array U133 Plus 2.0 (Genechip, Affymetrix) as described previously (Hamidi et al, 2012b) . Arrays were processed using the Affymetrix GeneChip Fluidic Station 450 and scanned using a GeneChip Scanner 3000 G7 (Affymetrix). The GeneChip Operating Software (Affymetrix GCOS v1.4) was used to obtain chip images with quality control conducted using the AffyQCReport software. 
Statistics
Figure 2
Nupr1 deficiency induces a decrease in ATP production by OXPHOS suppression. MiaPaCa2 cells were transfected with siCtrl or two different siRNA against Nupr1 for 48 h. Cells were then incubated with thapsigargin, brefeldin A, or tunicamycin at 1 μM for another 24 h period in the presence or not of Z-VAD-FMK 10 μM, and ATP production (A) was measured;
data values were normalized to the siCtrl. Mitochondrial respiration reflected by oxygen consumption rate (OCR) levels was measured in MiaPaCa2 cells transfected with siCtrl, siNUPR1-1 or siNUPR1-2 for 72 h (B). Mitochondrial respiration was also measured in three clones of Panc-1 control cells (with wild-type NUPR1), and six clones of Nupr1 knockout cells, developed by CRISPR-Cas9 technology. Data are means of triplicates ± SEM of the 3 control and 6 knockout clones (C). Finally, we measured mitochondrial respiration in pancreatic acinar cells from WT (Nupr1 +/+ ) and Nupr1 -/-, mice (D). Only statistically significant differences (p values ≤ 0.05) were shown. The OCR was measured under basal conditions or following the addition of oligomycin, FCCP, or rotenone/antimycin A. The rates of OCR for basal respiration, maximal respiration, spare capacity, and ATP production were quantified as described in the Materials and Methods section. The OCR was again determined in MiaPaCa2 cells transfected with siCtrl, siNUPR1-1, or siNUPR1-2 when cells were challenged with UK5099, BPTES, or etomoxir; inhibitors of glucose oxidation, glutaminase, and carnitine palmitoyl-transferase 1A, respectively (E). Total RNA was extracted to monitor the mRNA levels of the genes involved in the Krebs cycle using RT-qPCR (F). Data are means of triplicates ± SEM. For each treatment, statistically significant differences (p values ≤ 0.05) from siCtrl are shown.
Figure 3
Nupr1 deficiency promotes anaerobic glycolytic metabolism. Extracellular acidification rate (ECAR) levels were measured in MiaPaCa2 cells transfected with siCtrl, siNUPR1-1, or siNUPR1-2 for 72 h (A). The ECAR was measured in three clones of Panc-1 control cells (with wild-type Nupr1) and six clones of Nupr1 knockout cells, developed by CRISPR-Cas9 technology. Data are means of triplicates ± SEM of three control and six knockout clones (B).
Statistically significant differences from Panc-1 control cells with p values ≤ 0.05 are shown.
Also, the ECAR was measured in pancreatic acinar cells from WT (Nupr1 +/+ ) and Nupr1 -/mice (C). The ECAR was measured under basal conditions or following the addition of glucose, oligomycin, or 2-Deoxyglucose. The rates of ECAR for glycolysis, glycolytic capacity, and glycolytic reserve were quantified as described in the Materials and Methods section.
Lactate release (D), glucose (E) and glutamine (F) uptake and were measured in the extracellular medium after 24 h in culture. A representative image of DMEM collected after 72 h of culture is shown (D). ATP production by OXPHOS and anaerobic glycolysis were determined by the OCR and proton production rate, respectively (G); data values were normalized to the siCtrl. Total RNA was extracted to monitor mRNA levels of the genes involved in glycolysis using RT-qPCR (G) . Data are means of triplicates ± SEM. For each treatment, statistically significant (p values ≤ 0.05) differences from Nupr1 +/+ mice or siCtrl are shown.
Figure 4
Nupr1 deficiency leads to a mitochondrial membrane potential disruption inducing ROS overproduction. Flow cytometry analysis of MiaPaCa2 cells transfected with siCtrl, siNUPR1-1, or siNUPR1-2 for 72 h was carried out using MITO-ID for analysis of the mitochondrial membrane potential (A). MITO-ID was also applied to three clones of Panc-1 control cells (with wild-type NUPR1) and six clones of Nupr1 knockout cells, developed by CRISPR-Cas9 technology. Data are means of triplicates ± SEM of the 3 control and 6 knockout clones (B).
ROS production was detected using MitoSOX Red by flow cytometry analysis in the experimental cell groups as described above (C and D) . 
